![](/img/cover-not-exists.png)
PCN69 COST-EFFECTIVENESS OF ADDING CAPECITABINE TO TRASTUZUMAB AND DOCETAXEL AS FIRST LINE THERAPY FOR PATIENTS WITH HER-2-POSITIVE METASTATIC BREAST CANCER (HER2+MBC)—RESULTS FROM SPAIN, FRANCE AND ITALY
K Hieke, P Ducournau, F de Reydet de VulpillièresVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)74320-5
File:
PDF, 71 KB
english, 2009